Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis L Pisters

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
European Urology Oncology|July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node MetastasisAmado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.
Cancer|September 17, 2020
Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classificationsEric C Umbreit, Andrew G McIntosh, Chalairat Suk-Ouichai, et al.
BJUI Compass|April 27, 2022
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinomaOmar Alhalabi, Matthew T Campbell, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancerLouis L Pisters, Curtis A Pettaway, Patricia Troncoso, et al.
Cancers|December 17, 2020
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell TumorEric C Umbreit, Bilal A Siddiqui, Michael J Hwang, et al.
Oncotarget|November 19, 2016
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testisMehmet Asim Bilen, Kenneth R Hess, Matthew T Campbell, et al.
The New England Journal of Medicine|March 21, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivorsMartin G Sanda, Rodney L Dunn, Jeff Michalski, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
European Urology Oncology|July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node MetastasisAmado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.
Cancer|September 17, 2020
Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classificationsEric C Umbreit, Andrew G McIntosh, Chalairat Suk-Ouichai, et al.
BJUI Compass|April 27, 2022
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinomaOmar Alhalabi, Matthew T Campbell, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancerLouis L Pisters, Curtis A Pettaway, Patricia Troncoso, et al.
Cancers|December 17, 2020
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell TumorEric C Umbreit, Bilal A Siddiqui, Michael J Hwang, et al.
Oncotarget|November 19, 2016
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testisMehmet Asim Bilen, Kenneth R Hess, Matthew T Campbell, et al.
The New England Journal of Medicine|March 21, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivorsMartin G Sanda, Rodney L Dunn, Jeff Michalski, et al.
The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.
Pageof 17